Mergers & Acquisitions ·
Jin Medical completes $159M acquisition of Huaxia Qiying via VIE arrangement, issuing over 79 million shares
ZJYLJin Medical International Ltd.
Jin Medical International Ltd. completed the acquisition of contractual control over Huaxia Qiying (Beijing) Technology Co., Ltd. via a Variable Interest Entity arrangement on September 24, 2026. The aggregate purchase price was US$159,415,729, comprising share consideration and non-share assets including HTFX Investment Assets, Changzhou Muchi Investment Assets, Taizhou Muchi Investment Assets, Kangma Debt, and Kangma Equity. To fund the transaction, the Company issued 71,282,488 Class A ordinary shares to sellers and 8,479,560 Class A ordinary shares as financial advisory compensation. Post-closing, total outstanding shares increased to 158,194,533. The transfer of Kangma Equity remains pending with a deadline of October 31, 2026; failure to complete will result in the issuance of 622,123 substitute shares. Jin Medical International Ltd. operates in the medical technology and healthcare equipment industry.